Digoxin is a cardiac glycoside extracted from the leaves of the foxglove plant Digitalis lanata. Although the properties of digitalis extracts have been known since the dark ages, their cardiac effects were discovered by the Scottish doctor William Withering in 1776. According to the history, during the treatment of one of his patients, who had a severe heart condition to which no treatment was available at that time. As a last resource, the patient went to a local gypsy, who gave him a secret plant extract, which improved his condition considerably. Intrigued by the fact, Dr. Withering met the gypsy, who revealed that the active ingredient of her potion was an extract of a foxglove plant. Currently, digoxin is on the World Health Organizationās List of Essential Medicines.
The global Lanoxin API market is projected to grow from US$ 61 million in 2024 to US$ 73 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
In terms of production side, this report researches the Lanoxin API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Lanoxin API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Lanoxin API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Lanoxin API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Lanoxin API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lanoxin API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Lanoxin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Lanoxin API sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem
Segment by Type
Purity: ā„98%
Purity: <98%
Segment by Application
Tablet Product
Injection Product
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Lanoxin API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Lanoxin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Lanoxin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lanoxin API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Lanoxin API Product Introduction
1.2 Market by Type
1.2.1 Global Lanoxin API Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Purity: ā„98%
1.2.3 Purity: <98%
1.3 Market by Application
1.3.1 Global Lanoxin API Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Tablet Product
1.3.3 Injection Product
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Lanoxin API Production
2.1 Global Lanoxin API Production Capacity (2019-2030)
2.2 Global Lanoxin API Production by Region: 2019 VS 2023 VS 2030
2.3 Global Lanoxin API Production by Region
2.3.1 Global Lanoxin API Historic Production by Region (2019-2024)
2.3.2 Global Lanoxin API Forecasted Production by Region (2025-2030)
2.3.3 Global Lanoxin API Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Lanoxin API Revenue Estimates and Forecasts 2019-2030
3.2 Global Lanoxin API Revenue by Region
3.2.1 Global Lanoxin API Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Lanoxin API Revenue by Region (2019-2024)
3.2.3 Global Lanoxin API Revenue by Region (2025-2030)
3.2.4 Global Lanoxin API Revenue Market Share by Region (2019-2030)
3.3 Global Lanoxin API Sales Estimates and Forecasts 2019-2030
3.4 Global Lanoxin API Sales by Region
3.4.1 Global Lanoxin API Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Lanoxin API Sales by Region (2019-2024)
3.4.3 Global Lanoxin API Sales by Region (2025-2030)
3.4.4 Global Lanoxin API Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Lanoxin API Sales by Manufacturers
4.1.1 Global Lanoxin API Sales by Manufacturers (2019-2024)
4.1.2 Global Lanoxin API Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lanoxin API in 2023
4.2 Global Lanoxin API Revenue by Manufacturers
4.2.1 Global Lanoxin API Revenue by Manufacturers (2019-2024)
4.2.2 Global Lanoxin API Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Lanoxin API Revenue in 2023
4.3 Global Lanoxin API Sales Price by Manufacturers
4.4 Global Key Players of Lanoxin API, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Lanoxin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Lanoxin API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Lanoxin API, Product Offered and Application
4.8 Global Key Manufacturers of Lanoxin API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Lanoxin API Sales by Type
5.1.1 Global Lanoxin API Historical Sales by Type (2019-2024)
5.1.2 Global Lanoxin API Forecasted Sales by Type (2025-2030)
5.1.3 Global Lanoxin API Sales Market Share by Type (2019-2030)
5.2 Global Lanoxin API Revenue by Type
5.2.1 Global Lanoxin API Historical Revenue by Type (2019-2024)
5.2.2 Global Lanoxin API Forecasted Revenue by Type (2025-2030)
5.2.3 Global Lanoxin API Revenue Market Share by Type (2019-2030)
5.3 Global Lanoxin API Price by Type
5.3.1 Global Lanoxin API Price by Type (2019-2024)
5.3.2 Global Lanoxin API Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Lanoxin API Sales by Application
6.1.1 Global Lanoxin API Historical Sales by Application (2019-2024)
6.1.2 Global Lanoxin API Forecasted Sales by Application (2025-2030)
6.1.3 Global Lanoxin API Sales Market Share by Application (2019-2030)
6.2 Global Lanoxin API Revenue by Application
6.2.1 Global Lanoxin API Historical Revenue by Application (2019-2024)
6.2.2 Global Lanoxin API Forecasted Revenue by Application (2025-2030)
6.2.3 Global Lanoxin API Revenue Market Share by Application (2019-2030)
6.3 Global Lanoxin API Price by Application
6.3.1 Global Lanoxin API Price by Application (2019-2024)
6.3.2 Global Lanoxin API Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Lanoxin API Market Size by Type
7.1.1 US & Canada Lanoxin API Sales by Type (2019-2030)
7.1.2 US & Canada Lanoxin API Revenue by Type (2019-2030)
7.2 US & Canada Lanoxin API Market Size by Application
7.2.1 US & Canada Lanoxin API Sales by Application (2019-2030)
7.2.2 US & Canada Lanoxin API Revenue by Application (2019-2030)
7.3 US & Canada Lanoxin API Sales by Country
7.3.1 US & Canada Lanoxin API Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Lanoxin API Sales by Country (2019-2030)
7.3.3 US & Canada Lanoxin API Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Lanoxin API Market Size by Type
8.1.1 Europe Lanoxin API Sales by Type (2019-2030)
8.1.2 Europe Lanoxin API Revenue by Type (2019-2030)
8.2 Europe Lanoxin API Market Size by Application
8.2.1 Europe Lanoxin API Sales by Application (2019-2030)
8.2.2 Europe Lanoxin API Revenue by Application (2019-2030)
8.3 Europe Lanoxin API Sales by Country
8.3.1 Europe Lanoxin API Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Lanoxin API Sales by Country (2019-2030)
8.3.3 Europe Lanoxin API Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Lanoxin API Market Size by Type
9.1.1 China Lanoxin API Sales by Type (2019-2030)
9.1.2 China Lanoxin API Revenue by Type (2019-2030)
9.2 China Lanoxin API Market Size by Application
9.2.1 China Lanoxin API Sales by Application (2019-2030)
9.2.2 China Lanoxin API Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Lanoxin API Market Size by Type
10.1.1 Asia Lanoxin API Sales by Type (2019-2030)
10.1.2 Asia Lanoxin API Revenue by Type (2019-2030)
10.2 Asia Lanoxin API Market Size by Application
10.2.1 Asia Lanoxin API Sales by Application (2019-2030)
10.2.2 Asia Lanoxin API Revenue by Application (2019-2030)
10.3 Asia Lanoxin API Sales by Region
10.3.1 Asia Lanoxin API Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Lanoxin API Revenue by Region (2019-2030)
10.3.3 Asia Lanoxin API Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Lanoxin API Market Size by Type
11.1.1 Middle East, Africa and Latin America Lanoxin API Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Lanoxin API Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Lanoxin API Market Size by Application
11.2.1 Middle East, Africa and Latin America Lanoxin API Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Lanoxin API Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Lanoxin API Sales by Country
11.3.1 Middle East, Africa and Latin America Lanoxin API Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Lanoxin API Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Lanoxin API Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 C2 Pharma
12.1.1 C2 Pharma Company Information
12.1.2 C2 Pharma Overview
12.1.3 C2 Pharma Lanoxin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 C2 Pharma Lanoxin API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 C2 Pharma Recent Developments
12.2 Alkaloids Corporation
12.2.1 Alkaloids Corporation Company Information
12.2.2 Alkaloids Corporation Overview
12.2.3 Alkaloids Corporation Lanoxin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Alkaloids Corporation Lanoxin API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Alkaloids Corporation Recent Developments
12.3 Vital Labs
12.3.1 Vital Labs Company Information
12.3.2 Vital Labs Overview
12.3.3 Vital Labs Lanoxin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Vital Labs Lanoxin API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Vital Labs Recent Developments
12.4 Alchem
12.4.1 Alchem Company Information
12.4.2 Alchem Overview
12.4.3 Alchem Lanoxin API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Alchem Lanoxin API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Alchem Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Lanoxin API Industry Chain Analysis
13.2 Lanoxin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Lanoxin API Production Mode & Process
13.4 Lanoxin API Sales and Marketing
13.4.1 Lanoxin API Sales Channels
13.4.2 Lanoxin API Distributors
13.5 Lanoxin API Customers
14 Lanoxin API Market Dynamics
14.1 Lanoxin API Industry Trends
14.2 Lanoxin API Market Drivers
14.3 Lanoxin API Market Challenges
14.4 Lanoxin API Market Restraints
15 Key Finding in The Global Lanoxin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
C2 Pharma
Alkaloids Corporation
Vital Labs
Alchem
Ģż
Ģż
*If Applicable.
